Stock ABS ARCTIC BIOSCIENCE
Add to a list
To use this feature you must be a member
Log inSign up

Company Arctic Bioscience

Equities

ABS

NO0010859580

Pharmaceuticals

Market Closed - Oslo Bors
Other stock markets
 15:45:00 10/05/2024 BST 		5-day change 1st Jan Change
10.1 NOK -2.88% Intraday chart for Arctic Bioscience -3.81% -3.81%
03-01 Arctic Bioscience AS Reports Earnings Results for the Full Year Ended December 31, 2023 CI
03-01 Transcript : Arctic Bioscience AS, Q4 2023 Earnings Call, Mar 01, 2024

Business Summary

Arctic Bioscience AS is a Norway-based biotech company developing and commercializing both pharmaceutical and nutraceutical products based on the properties of herring roe oil. Arctic Bioscience’s purpose is to provide people with autoimmune disorders an effective and healthy therapy based on marine membrane lipids. The Company is developing HRO350 - a novel investigational drug candidate. HRO350 is being developed for treatment of patients with mild-to-moderate psoriasis. The Company's product portfolio includes, among others, Romega, which is a producer of an omega-3 dietary supplement made from herring roe in a form of a capsule, as well as herring caviar oil and herring caviar protein offered to Business-to-Business (B2B) customers. Arctic Bioscience AS has three subsidiaries Arctic Nutrition AS, Romega AS and Arctic Biopharma AS.

Number of employees: 17

Sales per Business

NOK in Million2022Weight2023Weight Delta
Business to Business
87.3 %
- - 29 87.3 % -
Business to Consumer
12.7 %
- - 4 12.7 % -

Sales per region

NOK in Million2022Weight2023Weight Delta
Europe
36.8 %
-- 12 36.8 % -
APAC
28.9 %
-- 10 28.9 % -
Norway
17.9 %
34 100.0 % 6 17.9 % -82.38%
Americas
16.4 %
-- 6 16.4 % -

Managers

Managers TitleAgeSince
Hogne Hallaråker FOU
 Founder 58 31/12/10
Christer Ludvig Valderhaug CEO
 Chief Executive Officer 52 28/02/22
Jone R. Slinning DFI
 Director of Finance/CFO 45 31/03/22
Runhild Gammelsæter CTO
 Chief Tech/Sci/R&D Officer 48 31/07/19
Daniele Mancinelli CTO
 Chief Tech/Sci/R&D Officer 51 30/06/12
Per Christian Sæbø COO
 Chief Operating Officer 57 31/03/12
Steffen Eidal SAM
 Sales & Marketing 58 -
Yuming Feng PRN
 Corporate Officer/Principal 61 -
Sigrun Lindhom Knardal PRN
 Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Tore Andreas Frøysa Tønseth BRD
 Director/Board Member 44 31/12/20
Jostein Christian Dalland BRD
 Director/Board Member 55 31/12/19
Harald Nordal FOU
 Founder 66 31/12/10
Jan Endre Vartdal BRD
 Director/Board Member 53 31/12/14
Per Magne Eggesbø BRD
 Director/Board Member 61 31/12/15
Asbjørn Solvågseide BRD
 Director/Board Member 64 31/12/18
Marita Holstad BRD
 Director/Board Member - 09/11/21
Hu Cao BRD
 Director/Board Member - 31/01/21

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 25,369,552 9,746,341 ( 38.42 %) 0 38.42 %

Shareholders

NameEquities%Valuation
Storebrand Asset Management AS
4.006 %
1,016,223 4.006 % 939 996 kr
Cicero Fonder AB
0.1834 %
46,520 0.1834 % 43 031 kr

Company contact information

Arctic Bioscience AS

Industrivegen 42

6155, Orsta

+

http://arctic-bioscience.com
address Arctic Bioscience(ABS)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Arctic Bioscience

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
10.4 NOK
Average target price
10 NOK
Spread / Average Target
-3.85%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ARCTIC BIOSCIENCE Stock Arctic Bioscience
-3.81% 24.25M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+31.22% 695B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.51% 568B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.58% 361B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.69% 330B
ABBVIE INC. Stock AbbVie Inc.
+3.89% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.70% 239B
NOVARTIS AG Stock Novartis AG
+8.78% 204B
ROCHE HOLDING AG Stock Roche Holding AG
-7.93% 198B
AMGEN INC. Stock Amgen Inc.
+9.03% 168B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. ABS Stock
  4. Company Arctic Bioscience